Please assess the completion status of the following clinical trial:

Trial Title: SEMPERFLO* Pain Management System in Inguinal Hernia Repair

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subject is a candidate for primary, non-emergent unilateral, open inguinal hernia repair procedure~* Subject is 18 years or older~* Subject must be willing to participate in the study, and provide informed consent to participate.~Exclusion Criteria:~* Subjects undergoing recurrent hernia repair;~* Subjects who plan to undergo another elective surgical procedure prior to the completion of this study;~* Subjects with known allergy to bupivacaine;~* Subjects with immunodeficiency diseases (including known HIV);~* Subjects with any findings identified by the surgeon that may preclude conduct of the study;~* Subjects who are known current alcohol and/or drug abusers;

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- SEMPERFLO Pain Management System (Type: EXPERIMENTAL): None
- ON-Q PainBuster Post-Op Pain Relief System (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).